Wegovy Cost Without Insurance: 2026 Pricing Guide

Wegovy Without Insurance: The Key Numbers

Wegovy (semaglutide) is Novo Nordisk's FDA-approved weight management medication, available as both a weekly injection pen and a new daily oral tablet (25 mg). Without insurance, the list price for Wegovy injection is approximately $1,349 per month — the highest list price among branded GLP-1 weight loss medications.

However, Novo Nordisk's savings program through NovoCare Pharmacy makes Wegovy substantially more accessible:

• New patients (uninsured, pen): $199/month for the first 2 months of 0.25 mg or 0.5 mg starter doses (limited-time offer through June 30, 2026)
• Ongoing (uninsured, pen): Pricing varies by dose; starter doses are the most affordable entry point
• New patients (uninsured, 1.5 mg or 4 mg doses): $149/month (4 mg offer available through August 31, 2026)
• With commercial insurance coverage: As little as $25/month (subject to $100/month maximum savings)

Wegovy Pricing: Every Option in 2026

Option 1: NovoCare Pharmacy Self-Pay (Lowest Cash Price)

The most affordable way to get Wegovy without insurance is through NovoCare Pharmacy, Novo Nordisk's direct-to-patient pharmacy with free home delivery. Current self-pay pricing:

These prices apply to patients using the Wegovy Savings Offer through NovoCare Pharmacy. Eligibility requires a valid Wegovy prescription and not being enrolled in a government healthcare program.

Option 2: Prescription Discount Services ($499–$650/month for Pens)

At retail pharmacies, prescription discount services like RxGo, GoodRx, and SingleCare can reduce Wegovy pen prices to approximately $499–$650/month depending on dose and location. This is significantly less than the $1,349 list price but more expensive than NovoCare Pharmacy pricing.

Compare Wegovy prices at pharmacies near you →

Option 3: Savings Card With Commercial Insurance ($25/month)

If you have commercial insurance that covers Wegovy, the Wegovy Savings Card reduces your cost to as little as $25 per month for a 1-month supply (28-day pen or 30-day tablet). The card covers savings up to $100/month. Government beneficiaries (Medicare, Medicaid, TRICARE) are excluded.

Option 4: NovoCare Patient Assistance (Low-Income Patients)

Patients without insurance who meet income eligibility requirements may qualify for free Wegovy through Novo Nordisk's patient assistance program. Visit novocare.com for eligibility criteria and application information.

Does Insurance Cover Wegovy?

Insurance coverage for Wegovy is improving but remains inconsistent. Here is the current landscape as of 2026:

Commercial insurance: Approximately 40–50% of commercial plans now cover Wegovy for chronic weight management. Coverage has expanded significantly since the SELECT trial (2023) demonstrated that Wegovy reduces cardiovascular events by 20% in patients with obesity and cardiovascular disease — a finding that strengthened the clinical case for coverage. Prior authorization is required by virtually all plans that do cover it.

Medicare: Medicare does not cover GLP-1 medications prescribed solely for weight loss. However, Wegovy's cardiovascular indication (reducing major cardiovascular events in adults with obesity and heart disease) may qualify some Medicare patients for coverage. This is a rapidly evolving area — check with your Medicare Part D plan for current formulary status.

Medicaid: Coverage varies by state. As of 2026, fewer than 25 states cover GLP-1 medications for obesity under Medicaid. Contact your state Medicaid office for current information.

Employer plans: Many large employers have added Wegovy coverage in 2025–2026 as evidence of long-term cost savings (reduced hospitalizations, fewer cardiovascular events) has accumulated. If your employer recently updated its benefits, it is worth re-checking your formulary.

Prior Authorization for Wegovy: What Your Doctor Needs

Prior authorization for Wegovy typically requires documentation of:

• BMI ≥ 30 kg/m² (obesity), or BMI ≥ 27 kg/m² with at least one weight-related comorbidity (hypertension, type 2 diabetes, sleep apnea, cardiovascular disease)
• Evidence of participation in a structured weight management program (diet and exercise counseling)
• No personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
• No history of pancreatitis

If your initial PA is denied, you can appeal. The SELECT trial data is a powerful tool for appeals — your doctor can cite the 20% reduction in cardiovascular events as evidence of medical necessity, particularly if you have cardiovascular disease.

Wegovy vs. Zepbound: Which Is Cheaper Without Insurance?

Both Wegovy and Zepbound are FDA-approved for chronic weight management, but they use different active ingredients and have very different self-pay pricing structures:

For new uninsured patients starting on the lowest dose, Wegovy's $199 introductory offer is currently cheaper than Zepbound's $299 starting vial price. For ongoing treatment at higher doses, Zepbound vials ($449/month) may be more affordable than Wegovy at maintenance doses. See our full Wegovy vs. Zepbound comparison for a complete analysis.

The New Wegovy Pill: What It Costs

In 2025, Novo Nordisk launched Wegovy as a daily oral tablet (25 mg), giving patients an alternative to weekly injections. The tablet is the same semaglutide active ingredient in a different formulation.

Cost of Wegovy pill without insurance:

• New patients through NovoCare Pharmacy: $199/month for the first 2 fills (introductory offer through June 30, 2026)
• With commercial insurance coverage: As little as $25/month

The pill requires a higher dose of semaglutide than the injection to achieve equivalent blood levels, which is why the tablet dose (25 mg) is much higher than the injection dose (2.4 mg). Efficacy data for the oral formulation is still accumulating, but early trials show comparable weight loss to the injection in most patients.

How to Get Wegovy for the Lowest Price: Step-by-Step

1. Check your insurance first. Call member services and ask if Wegovy is on your formulary. If covered, use the Wegovy Savings Card to pay as little as $25/month.

2. If not covered, use NovoCare Pharmacy. New patients pay $199/month for the first 2 fills of starter doses (through June 30, 2026). Set up free home delivery at novocare.com/patient/medicines/wegovy.html.

3. Compare retail pharmacy prices. Use RxGo or GoodRx to compare prices at pharmacies near you before filling your prescription at retail.

4. Consider the oral tablet. If injection anxiety is a barrier, the Wegovy pill is available at the same NovoCare pricing and may be easier to incorporate into your routine.

5. Apply for patient assistance if income-eligible. Novo Nordisk's patient assistance program provides free Wegovy to qualifying patients. Apply through your prescribing provider.

Frequently Asked Questions

Is Wegovy the same as Ozempic? Both contain semaglutide, but they are different FDA-approved products. Ozempic is approved for type 2 diabetes and cardiovascular risk reduction; Wegovy is approved for chronic weight management. Wegovy uses a higher maximum dose (2.4 mg injection vs. 2 mg for Ozempic) and has different insurance coverage and pricing programs.

Why is Wegovy so expensive? Wegovy is a biologic injectable medication with no generic equivalent. The high list price reflects manufacturing complexity, R&D investment, and the absence of competition. Biosimilar semaglutide is not expected until the early 2030s.

Can I use GoodRx for Wegovy? Yes, but NovoCare Pharmacy pricing ($199/month for new patients) is typically lower than GoodRx retail coupon prices for uninsured patients.

Does Wegovy work better than Ozempic for weight loss? Wegovy uses a higher maximum dose of semaglutide (2.4 mg vs. 2 mg for Ozempic) and is specifically dosed and titrated for weight loss. Clinical trials show average weight loss of ~15% of body weight with Wegovy. Ozempic trials show ~5–10% weight loss, partly because the dose is lower. See our Ozempic vs. Wegovy comparison for the full breakdown.

How long do I need to take Wegovy? Wegovy is a chronic medication. Weight typically returns when the medication is stopped. Most clinical guidelines recommend continuing treatment indefinitely for patients who respond well and tolerate the medication.